EU Clinical Trial 2018-003926-10

Prospective comparison of 18F-choline PET/CT and 18F-FDG PET/CT in the initial work-up of Multiple Myeloma  Feb 13, 2019

Main objective of the trial: To compare FCH-PET and FDG-PET for the number of bone lesions detected and confirmed by reference test in patients with newly diagnosed MM and not yet treated

Parties

Sponsors
Countries
FR
Keywords
FLUCIS 250 MBq/mL Multiple myeloma PROSTATEP 500 MBq/mL, solution injectable

JSON preview

Similar records

Title

Source:  EMA Last updated:  May 30, 2019

From ClinicalTrialsRegister.eu, a database of the European Medicines Agency. This record may not reflect the most current and accurate data available from the EMA.